Skip to main content
. 2018 Feb 21;8:3380. doi: 10.1038/s41598-018-21713-2

Table 2.

Non-satisfaction events in UK and Geneva according to candidate predictor category*.

Variable COASt (sample = 450) GAR (sample = 791)
n (%) n (%) n (%) n (%)
Women/Men 41 (15.6) 23 (12.2) 111 (21.1) 46 (17.3)
Age (mean ± sd years, range) 71 ± 7 50 to 84 69 ± 10 22 to 87
Lower/higher education 42 (14.3) 12 (14.0) 86 (19.3) 24 (16.3)
BMI <35/≥35Kg/m2 42 (12.0) 22 (21.8) 129 (19.4) 28 (22.2)
OKS/WOMAC <25%/≥25% 22 (22.5) 39 (12.6) 38 (27.9) 85 (16.8)
RA-other MSK condition/OA 5 (9.1) 56 (14.6) 24 (25.0) 133 (19.1)
0/1 co-morbidity 9 (9.3) 15 (12.7) 47 (23.2) 52 (17.1)
2/3 or more co-morbidities 20 (15.3) 20 (19.2) 42 (21.3) 16 (18.4)
Current/Ex- or non-smoker 5 (27.8) 55 (13.9) 25 (28.1) 130 (18.8)
Treated for anxiety/Non- 12 (26.7) 49 (13.3) 16 (20.8) 141 (19.8)
Treated for depression/Non- 17 (21.0) 41 (12.5) 22 (24.2) 135 (19.3)
Injected corticosteroids/Non- 8 (8.1) 52 (16.8) 19 (19.2) 138 (19.9)
Surgeon experience >8 years/less training 29 (16.2) 26 (12.3) 91 (19.3) 66 (20.6)

*Values are the number (%) unless indicated otherwise. Clinical outcomes in arthroplasty study, COASt; Geneva arthroplasty registry, GAR; standard deviation, sd; Lower education = illiterate, General Certificate of Secondary education, O and A level; Higher Educastion = diploma/degree/Doctor of Philosophy; body mass index, BMI; Oxford knee score, OKS; Western Ontario & McMaster Universities Osteoarthritis Index, WOMAC; rheumatoid arthritis, RA; musculoskeletal, MSK; osteoarthritis, OA.